Dr. Yogeeta Goyal Agrawal

Professor & HOD

Qualification: M. Pharm., Ph.D.

Specialization: Pharmaceutics Email ID: yogeeta.goyal@svkm.ac.in

Phone: +91-9421270813

Experience: 18 Years

• 30.04.2021 – Present:
  Institute : Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, MH
  Position : Professor of Pharmaceutics
• 1.02.2013 – 29.04.2021 (8.2 years): Institute : R.C Patel Institute of Pharmaceutical Education and Research, Shirpur.
  Position : Associate Professor of Pharmaceutics (23.04.2018 – 30.04.2021)
  Assistant Professor of Pharmaceutics (01.02.2013 – 22.04.2018)
• 1.01.2011-30.01.2013(2 Years):
  Institute: All India Institute of Medical Sciences
  Position: Senior Research fellow
• 20.06.2009-30.07.2011(2.1 Years)
  Institute: I.E.C College of Pharmacy, Greater–Noida
  Position: Assistant Professor
• 1.07.2004-31.01.2007(2.6 Years)
  IPCA Pharma, Nagpur headquarter
  Position: Professional Service Officer

Interest Areas: Nanotechnology

Research:

• Publications:
  • International: 40
  • National: 03
• Books: Nil
• Book Chapters: Nil
• Patents: 01
• Presentations:
  • International: 02
  • National: 12
• Completed Government Funded Projects: 01(24 Lacs) 1. Role: Principal Investigator
  Area of Project: Nanotechnology
  Name of Governing Body: DBT, Govt. of India
  

Industry Projects:

Completed: Nil
Ongoing: Nil

Conferences/Workshops/Seminars attended: 42

Academic Activities:

Ph.D.: Awarded: 02 Registered: 04

M. Pharm Guided: 25

B. Pharm Guided: 40

Awards:

• Stood First in the order of Merit in the M.S University during Masters in Pharmacy.
• Gold Medal by MSU Pharmacy Alumina Association at Post Graduation level for securing the highest percentage in University.
• Gold Medal by Indian Pharmaceutical Association (IPA) at Graduation level for securing the highest percentage in university.
• Received Nine Gold Medals from Nagpur University for securing the highest marks in each subject from different sponsors.
• G. P. Nair Award from Indian Drug Manufacturers Association(IDMA) for university topper in RTM Nagpur Univ. in B Pharmacy
• Received Outstanding Performance award on the basis of API Evaluation in R.C Patel Institute of Pharmaceutical Education and Research, Shirpur for the academic year 2017-18.
• Received Outstanding Performance award on the basis of API Evaluation in SVKMs Institute for Pharmacy, Dhule for the academic year 2021-22.

Professional Membership:

1. Indian Pharmaceutical Association (Life Time membership MAH/DHUL/LM/0032)

2. The Association of Pharmaceutical Teachers of India (Life Time membership MA/LM-2494)

3. Registered Pharmacist under Maharashtra State Pharmacy Council (Certificate No-74757)

4. MSU Pharmacy Alumni Association (Life time membership)

Recent Publications:

Tanaya D. Khairnar, Gaurav S. Chavan, Meenaz M. Sayyed, Nayan A. Gujarathi, Abhijeet A. Aher, Yogeeta O. Agrawal, Tulshidas S. Patil,Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review,Journal of Drug Delivery Science and Technology,Volume 98,2024,105890,ISSN 1773-2247,https://doi.org/10.1016/j.jddst.2024.105890.

Pawar HD, Patil Y, Patil A, Nakhate KT, Agrawal YO, Suchal K, Ojha S, Goyal SN. Cardioprotective effect of CB-1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice. Heliyon. 2024 Jul 24.

Patil K, Gujarathi N, Sharma C, Ojha S, Goyal S, Agrawal Y. Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation. Pharmaceutics. 2024; 16(7):910. https://doi.org/10.3390/pharmaceutics16070910.

Patil TS, Gujarathi NA, Aher AA, Pachpande HE, Sharma C, Agrawal YO. Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery. Int J Mol Sci. 2023 Feb 3;24(3):2978. doi: 10.3390/ijms24032978.

Rathod, S.S.; Agrawal, Y.O.; Nakhate, K.T.; Meeran, M.F.N.; Ojha, S.Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of EndocannabinoidSystem. Biomedicines 2023, 11,2642.

Rathod SS, Agrawal YO.Phytocannabinoids as Potential MultitargetingNeuroprotectants in Alzheimer's Disease. Curr Drug Res Rev. 2023 May 2. doi: 10.2174/2589977515666230502104021.

Baghel M, Sakure K, Giri TK, Maiti S, Nakhate KT, Ojha S, Sharma C, Agrawal Y, Badwaik H. Carboxymethylated Gums and Derivatization: Strategies and Significance in Drug Delivery and Tissue Engineering. Pharmaceuticals (Basel). 2023 May 22;16(5):776. doi: 10.3390/ph16050776.

Agrawal YO, Husain M, Patil KD, Sodgir V, Patil TS, Agnihotri VV, Mahajan HS. Verapamil hydrochloride loaded solid lipid nanoparticles: Preparation, optimization, characterisation, and assessment of cardioprotective effect in experimental model of myocardial infarcted rats. Biomed Pharmacother. 2022 Oct;154:113429. doi: 10.1016/j.biopha.2022.113429. Epub 2022 Aug 22. PMID: 36007280.

Prajapati C, Agrawal YO, Agnihotri VV, Mahajan UB, Patil KR, Patil DD, Patil CR. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis. Int J BiolMacromol. 2022 Aug 1;214:391-401. doi: 10.1016/j.ijbiomac.2022.06.070. Epub 2022 Jun 14. PMID: 35714868.

Yogeeta O. Agrawal, Kiran D. Patil, Kamini R. More, Mohd Usman Mohd Siddique, SaadAlkahtani, Nada H. Aljarba, MdSaquibHasnain,Amelioration of bioavailability through formulating and optimizing Azilsartan Entrapped nanostructured lipid carriers and its pharmacokinetic assessment,Journal of Drug Delivery Science and Technology,Volume 77,2022,103894,ISSN 1773-2247,https://doi.org/10.1016/j.jddst.2022.103894.

Shirsath K, Agrawal YO. Intranasal Nanoemulsions A Potential Strategy for Targeting The Neurodegenerative Disorder: Parkinson's. CNS NeurolDisord Drug Targets. 2022 Jun 22. doi: 10.2174/1871527321666220622163403.

Premkumar S. Baviskar, Hitendra S. Mahajan, Sachin M. Chandankar, Yogeeta O. Agrawal,Development and evaluation of N-acetyl glucosamine-decorated vitamin-E-based micelles incorporating resveratrol for cancer therapy,Journal of Drug Delivery Science and Technology,Volume 78,2022,103965,ISSN 1773-2247,https://doi.org/10.1016/j.jddst.2022.103965.

Agrawal Y, Patil K, Mahajan H, Potdar M, Joshi P, Nakhate K. S. In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach. Drug Deliv. 2022 Dec;29(1):1112-1121. doi: 10.1080/10717544.2022.2058651. PMID: 35380091; PMCID: PMC8986208.

Nakhate KT, Badwaik H, Choudhary R, Sakure K, Agrawal YO, Sharma C, OjhaS.Therapeutic Potential and Pharmaceutical Development of a Multitargeted Flavonoid Phloretin. Nutrients. 2022 Sep 2;14(17):3638. doi: 10.3390/nu14173638.

Pawar GR, Agrawal YO, Nakhate KT, Patil CR, Sharma C, Ojha S, Mahajan UB. Ghrelin alleviates depression-like behaviour in rats subjected to high-fat diet and diurnal rhythm disturbance. Am J Transl Res. 2022 Oct 15;14(10):7098-7108.

Rathod, S.; Agrawal, Y.; Sherikar, A.; Nakhate, K.T.; Patil, C.R.; NagoorMeeran, M.F.; Ojha, S. Thymoquinone Produces Cardioprotective Effect in β-Receptor Stimulated Myocardial Infarcted Rats via Subsiding Oxidative Stress and Inflammation. Nutrients 2022, 14, 2742. https://doi.org/10.3390/nu14132742ORATION

Muzammil Husain, Vinit V. Agnihotri, Yogeeta O. Agrawal, Development, optimization and characterization of hydrocolloid based mouth dissolving film of Telmisartan for the treatment of hypertension, Food Hydrocolloids for Health, Volume 2,2022,100064, ISSN 2667-0259.

Pawar HD, Mahajan UB, Nakhate KT, Agrawal YO, Patil CR, Meeran MFN, Sharma C, Ojha S, Goyal SN. Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors. Life. 2022; 12(5):624. https://doi.org/10.3390/life12050624.

Agnihotri, V.; Agrawal, Y.; Sharma, C.; Ojha, S. An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension. Molecules 2022, 27, 3490. https://doi.org/10.3390/molecules27113490

Muzammil Husain1 and Yogeeta O. Agrawal.Antimicrobial Remedies and Emerging Strategies for the Treatment of Diabetic Foot Ulcers. Is accepted for publication in Current Diabetes Reviews, Bentham Science. 24 Jan 2022

Agrawal YO, Priyanka Patil, Kiran Patil, Hitendra Mahajan, Darpan Shah, Nayan Gujarathi. Development, Characterization, In-vitro and pharmacokinetic evaluation of Xa inhibitor Apixaban Loaded Nanostructured Lipid Carriers Optimized by Quality-By-Design Approach. Is accepted for publication in Drug Delivery Journal.2022 Jan 3

Milind V. Masule, Sumit Rathod, Yogeeta Agrawal, Chandragouda R. Patil, Kartik T. Nakhate, ShreeshOjha, Umesh B. Mahajan.Ghrelin mediated regulation of neuro synaptic transmitters in depressive disorders,Current Research in Pharmacology and Drug Discovery,Volume 3,2022,100113,ISSN 2590-2571,https://doi.org/10.1016/j.crphar.2022.100113.

Agrawal YO, Mahajan UB, Agnihotri VV, Nilange MS, Mahajan HS, Sharma C, Ojha S, Patil CR,.Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation AmelioratesHyperlipidaemia in an Experimental Model of High Fat Diet. Molecules. 2021 Mar 9;26(5):1485 (Impact factor-3.267)

Agrawal Y. O., Mahajan H.S., Mahajan U.B, OjhaS.Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. Int J Nanomedicine 2020 Jul 7; 15:4763-4778. (Impact factor-5.12)

Ashwani S. Patil, Umesh B. Mahajan, Yogeeta O. Agrawal, Kalpesh R. Patil, Chandragouda R. Patil, ShreeshOjha, Charu Sharma. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review,Biomedicine & Pharmacotherapy,Volume 132,2020,110889, ISSN 0753-3322.

Redasani VK, Agrawal YO, Jagtap MS, Mahajan HS and Surana SJ. Analytical Method Development and Validation of Flecainide Acetate by Chromatographic and Spectrophotometric Techniques. Medicinal and Analytical chemistry 2020 December 08;4(2):ISSN 2639-2534.

Agrawal Y. O., Waghe D. C., Agnihotri V.V. & Mahajan H. S. Analytical Method Development and Validation of OlmesartanMedoxomil by Chromatographic and Spectrophotometric Techniques . THE PHARMA REVIEW. MARCH - APRIL 2019.

Umesh B Mahajan, GovindChandrayan, Chandragouda R Patil, Dharamvir Singh Arya, KapilSuchal, Yogeeta Agrawal. Eplerenone attenuates myocardial infarction in diabetic rats via modulation of the PI3K-Akt pathway and phosphorylation of GSK-3β. Am J Transl Res 2018;10(9):2810-2821(Impact factor-3.061)

Umesh B. Mahajan,Pradip D. Patil,GovindChandrayan,Chandragouda R. Patil,Yogeeta O. Agrawal. Eplerenonepretreatment protects the myocardium against ischaemia/ reperfusion injury through the phosphatidylinositol 3-kinase/Akt dependent pathway in diabetic rats. Molecular and Cellular Biochemistry 6 Jan 2018. (Impact factor-4.400)

Mahajan UB,ChandrayanG, Patil CR, AryaDS,Suchal K,Agrawal YO,Ojha S.The ProtectiveEffect of Apigeninon Myocardial Injury inDiabeticRatsmediating Activationof thePPAR-γPathway.IntJ MolSci. 2017 Apr4;18(4).(Impactfactor-3.9)

Goyal SN, Mahajan UB, Chandrayan G, Kumawat VS, Kamble S, Patil P,Agrawal YO, Patil CR,OjhaS.Protectiveeffectofoleanolicacidonoxidativeinjuryandcellularabnormalitiesindoxorubicin induced cardiac toxicity in rats. Am J. Transl Res. 2016 Jan 15; 8(1):60-9. (Impact factor-3.15)

Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, Agrawal YO. Challenges and issueswithstreptozotocin-induceddiabetes-Aclinicallyrelevantanimalmodeltounderstandthediabetes pathogenesis and evaluate therapeutics. ChemBiol Interact. 2016 Jan 25; 244:49-63. (Impactfactor- 2.577)

Reddy NM, Mahajan UB, Patil CR, Agrawal YO, Ojha S, Goyal SN. Eplerenone attenuates cardiacdysfunctionand oxidativestress in β-receptorstimulated myocardialinfarcted rats. Am JTranslRes.2015 Sep15;7(9):1602-11.(Impactfactor-3.402)

Sharma C, Mahajan UB, Patil CR, Agrawal YO, Kumari S, Arya DS, Ojha S. ProtectiveEffectsofCardamominIsoproterenol-InducedMyocardialInfarctioninRats.IntJMolSci.2015Nov17; 16(11):27457-69.(Impactfactor-4.556)

Agrawal YO, Sharma PK, Shrivastava B, Ojha S, Upadhya HM, Arya DS..Hesperidinproduces cardioprotective activity via PPAR-γ pathway in ischemicheart disease model in diabeticrats.PLoSOne. 2014 Nov4; 9(11):e111212.(Impactfactor-3.534)

Agrawal YO, Sharma PK, Shrivastava B, Arya DS. Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering ofPPAR-γ receptor. ChemBiol Interact.2014Aug 5;219:211-20.doi:10.1016/j.cbi.2014.06.010.(Impact factor- 2.577)

Bharti S, Krishnamurthy B, Agrawal Y, Ojha SK, Arya DS. Impact of metabolic syndromeon re-stenosis development: role of drug-eluting stents. DiabVasc Dis Res. 2012 Jul;9(3):177-88. doi:10.1177/1479164111430336.Review.(Impact factor-2.468)

AgrawalY,PetkarKC,SawantKK.Development,evaluationandclinicalstudiesofAcitretinloaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 2010 Nov 30;401(1-2):93-102.doi:10.1016/j.ijpharm.2010.09.007.(Impact factor-4.845)